Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Comment: Combining tamoxifen with ovarian suppression reduced recurrence of...

Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA

Comment: Combining tamoxifen with ovarian suppression reduced recurrence of some breast cancers ( Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA )

BOLERO-1 reports HER2-positive breast cancer latest PFS data

Prof Sara Hurvitz - University of California, Los Angeles, USA

BOLERO-1 reports HER2-positive breast cancer latest PFS data ( Prof Sara Hurvitz - University of California, Los Angeles, USA )

Comment: Tamoxifen lowered breast cancer rates among high-risk women

Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA

Comment: Tamoxifen lowered breast cancer rates among high-risk women ( Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA )

Impact of adding bevacizumab to presurgery chemo for triple-negative breast...

Dr William Sikov - Women and Infants Hospital, Providence, USA

Impact of adding bevacizumab to presurgery chemo for triple-negative breast cancer varies with subtype ( Dr William Sikov - Women and Infants Hospital, Providence, USA )

Fulvestrant improves survival over anastrozole for patients with advanced...

Prof John Robertson - Royal Derby Hospital, Derby, UK

Fulvestrant improves survival over anastrozole for patients with advanced breast cancer ( Prof John Robertson - Royal Derby Hospital, Derby, UK )

Progression-free survival results from BOLERO-1 trial

Prof Sara Hurvitz - University of California, Los Angeles, USA

Progression-free survival results from BOLERO-1 trial ( Prof Sara Hurvitz - University of California, Los Angeles, USA )

Lowering dietary fat intake reduces death rates in some women with breast cancer

Prof Rowan Chlebowski - Harbor-UCLA Medical Centre, Torrance, USA

Lowering dietary fat intake reduces death rates in some women with breast cancer ( Prof Rowan Chlebowski - Harbor-UCLA Medical Centre, Torrance, USA )

Multigene test can predict risk of disease recurrence for women with ductal...

Prof Eileen Rakovitch - Sunnybrook Research Institute, Toronto, Canada

Multigene test can predict risk of disease recurrence for women with ductal carcinoma in situ ( Prof Eileen Rakovitch - Sunnybrook Research Institute, Toronto, Canada )

Ovarian suppression with tamoxifen reduced recurrence in some premenopausal...

Dr Prudence Francis - Peter MacCallum Cancer Centre, Melbourne, Australia

Ovarian suppression with tamoxifen reduced recurrence in some premenopausal breast cancer cases ( Dr Prudence Francis - Peter MacCallum Cancer Centre, Melbourne, Australia )

Comment: Capecitabine for elderly early-stage breast cancer

Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA

Comment: Capecitabine for elderly early-stage breast cancer ( Prof Carlos Arteaga - Vanderbilt-Ingram Cancer Center, Nashville, USA )

Capecitabine monotherapy does not improve survival in elderly patients with...

Prof Gunter von Minckwitz – German Breast Group, Neu-Isenburg, Germany

Capecitabine monotherapy does not improve survival in elderly patients with early-stage breast cancer ( Prof Gunter von Minckwitz – German Breast Group, Neu-Isenburg, Germany )

Impact of adding bevacizumab to presurgery chemo for triple-negative breast...

Dr William Sikov - Women and Infants Hospital, Providence, USA

Impact of adding bevacizumab to presurgery chemo for triple-negative breast cancer varies with subtype ( Dr William Sikov - Women and Infants Hospital, Providence, USA )

More from ecancer